Clinical Trial Update: Establishing the Salience of Type 1 Interferon Pathway Blockade in the Central Mechanisms of SLE Related Fatigue

View source ↗

Summary

This clinical trial update investigates the role of blocking Type I interferon signaling in the central mechanisms underlying fatigue in systemic lupus erythema…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Interferon pathway blocker (investigational)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Systemic Lupus Erythematosus | Status: NOT_YET_RECRUITING